[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fenATY9Ce9cyibrlmsYbM8m-iASc1W1W8mLUrSn7Sfbc":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":9,"nonDrugCount":11,"topConditions":12,"upcomingReadouts":34,"phaseBuckets":45,"rows":52},"Florida International University",[4],101,false,27,2,18114,89,[13,16,18,21,24,26,29,32],{"name":14,"count":15},"Attention Deficit Hyperactivity Disorder",7,{"name":17,"count":15},"ADHD",{"name":19,"count":20},"HIV Infections",6,{"name":22,"count":23},"Parenting",5,{"name":25,"count":23},"Anxiety Disorders",{"name":27,"count":28},"Electronic Cigarette Use",4,{"name":30,"count":31},"Medication Adherence",3,{"name":33,"count":31},"Behavior Problem",[35,40],{"nctId":36,"briefTitle":37,"date":38,"intervention":39},"NCT05469386","Single and Combined Effects of Behavioral, Academic, and Medication Treatments for ADHD in the Classroom","2025-08-08","Methylphenidate Hydrochloride ER",{"nctId":41,"briefTitle":42,"date":43,"intervention":44},"NCT04787848","Chronic Widespread Pain in HIV: Novel Mechanisms and Therapeutics","2026-07-30","Relistor Injectable Product",[46,47,48,49,50,51],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[53,77,99,136,161,185,210,234,259,284,311,329,347],{"intervention":39,"totalTrials":54,"cells":55},1,{"EARLY_PHASE1":56,"PHASE1":59,"PHASE2":61,"PHASE3":63,"PHASE4":65,"NA":75},{"trials":57,"activeCount":58},[],0,{"trials":60,"activeCount":58},[],{"trials":62,"activeCount":58},[],{"trials":64,"activeCount":58},[],{"trials":66,"activeCount":54,"soonestReadout":38},[67],{"nctId":36,"briefTitle":37,"status":68,"phases":69,"primaryCompletion":38,"completion":70,"start":71,"enrollment":72,"conditions":73,"interventions":74},"ACTIVE_NOT_RECRUITING",[50],"2026-08-31","2022-06-13",288,[17],[39],{"trials":76,"activeCount":58},[],{"intervention":44,"totalTrials":54,"cells":78},{"EARLY_PHASE1":79,"PHASE1":81,"PHASE2":83,"PHASE3":85,"PHASE4":87,"NA":89},{"trials":80,"activeCount":58},[],{"trials":82,"activeCount":58},[],{"trials":84,"activeCount":58},[],{"trials":86,"activeCount":58},[],{"trials":88,"activeCount":58},[],{"trials":90,"activeCount":54,"soonestReadout":43},[91],{"nctId":41,"briefTitle":42,"status":92,"phases":93,"primaryCompletion":43,"completion":43,"start":94,"enrollment":95,"conditions":96,"interventions":98},"RECRUITING",[51],"2021-11-15",200,[97],"Chronic Widespread Pain",[44],{"intervention":100,"totalTrials":9,"cells":101},"Methylphenidate",{"EARLY_PHASE1":102,"PHASE1":104,"PHASE2":106,"PHASE3":108,"PHASE4":120,"NA":134},{"trials":103,"activeCount":58},[],{"trials":105,"activeCount":58},[],{"trials":107,"activeCount":58},[],{"trials":109,"activeCount":58},[110],{"nctId":111,"briefTitle":112,"status":113,"phases":114,"primaryCompletion":115,"completion":115,"start":116,"enrollment":117,"conditions":118,"interventions":119},"NCT02502799","Intervention for Teens With ADHD and Substance Use","TERMINATED",[49],"2021-08","2015-07",158,[14],[100],{"trials":121,"activeCount":58},[122],{"nctId":123,"briefTitle":124,"status":125,"phases":126,"primaryCompletion":127,"completion":128,"start":129,"enrollment":130,"conditions":131,"interventions":133},"NCT02039908","Examining Tolerance to CNS Stimulants in ADHD","COMPLETED",[50],"2018-05","2020-03","2013-04",267,[132],"Attention-deficit\u002FHyperactivity Disorder",[100],{"trials":135,"activeCount":58},[],{"intervention":137,"totalTrials":54,"cells":138},"Fluoxetine",{"EARLY_PHASE1":139,"PHASE1":141,"PHASE2":143,"PHASE3":145,"PHASE4":147,"NA":159},{"trials":140,"activeCount":58},[],{"trials":142,"activeCount":58},[],{"trials":144,"activeCount":58},[],{"trials":146,"activeCount":58},[],{"trials":148,"activeCount":58},[149],{"nctId":150,"briefTitle":151,"status":125,"phases":152,"primaryCompletion":153,"completion":153,"start":154,"enrollment":155,"conditions":156,"interventions":158},"NCT02916238","Measurement-based Care for Depression in Resource-Poor Settings",[50],"2016-11","2014-02",140,[157],"Major Depression",[137],{"trials":160,"activeCount":58},[],{"intervention":162,"totalTrials":54,"cells":163},"lisdexamfetamine",{"EARLY_PHASE1":164,"PHASE1":166,"PHASE2":168,"PHASE3":170,"PHASE4":172,"NA":183},{"trials":165,"activeCount":58},[],{"trials":167,"activeCount":58},[],{"trials":169,"activeCount":58},[],{"trials":171,"activeCount":58},[],{"trials":173,"activeCount":58},[174],{"nctId":175,"briefTitle":176,"status":125,"phases":177,"primaryCompletion":178,"completion":178,"start":179,"enrollment":180,"conditions":181,"interventions":182},"NCT01127607","Does Pharmacological Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults Enhance Parenting Performance?",[50],"2012-07","2010-11",38,[17],[162],{"trials":184,"activeCount":58},[],{"intervention":186,"totalTrials":54,"cells":187},"Stimulant",{"EARLY_PHASE1":188,"PHASE1":190,"PHASE2":192,"PHASE3":194,"PHASE4":196,"NA":208},{"trials":189,"activeCount":58},[],{"trials":191,"activeCount":58},[],{"trials":193,"activeCount":58},[],{"trials":195,"activeCount":58},[],{"trials":197,"activeCount":58},[198],{"nctId":199,"briefTitle":200,"status":201,"phases":202,"primaryCompletion":203,"completion":203,"start":204,"enrollment":58,"conditions":205,"interventions":207},"NCT03511976","Adaptive Response to Intervention (RTI) for Students With ADHD","WITHDRAWN",[50],"2023-10-21","2018-05-14",[206],"Attention Deficit Disorder With Hyperactivity",[186],{"trials":209,"activeCount":58},[],{"intervention":211,"totalTrials":54,"cells":212},"Extended release (ER) methylphenidate product",{"EARLY_PHASE1":213,"PHASE1":215,"PHASE2":217,"PHASE3":219,"PHASE4":230,"NA":232},{"trials":214,"activeCount":58},[],{"trials":216,"activeCount":58},[],{"trials":218,"activeCount":58},[],{"trials":220,"activeCount":58},[221],{"nctId":222,"briefTitle":223,"status":125,"phases":224,"primaryCompletion":225,"completion":225,"start":179,"enrollment":226,"conditions":227,"interventions":229},"NCT01109849","Novel Approach to Stimulant Induced Weight Suppression and Its Impact on Growth",[49],"2016-04",230,[17,228],"Growth",[211],{"trials":231,"activeCount":58},[],{"trials":233,"activeCount":58},[],{"intervention":235,"totalTrials":54,"cells":236},"Soluble Corn Fiber (SCF) + Calcium",{"EARLY_PHASE1":237,"PHASE1":239,"PHASE2":241,"PHASE3":253,"PHASE4":255,"NA":257},{"trials":238,"activeCount":58},[],{"trials":240,"activeCount":58},[],{"trials":242,"activeCount":58},[243],{"nctId":244,"briefTitle":245,"status":125,"phases":246,"primaryCompletion":247,"completion":247,"start":248,"enrollment":249,"conditions":250,"interventions":252},"NCT02916862","Effect of Soluble Corn Fiber Supplementation for 1 Year on Bone Metabolism in Adolescents",[48],"2025-04-30","2020-02-10",177,[251],"Osteoporosis",[235],{"trials":254,"activeCount":58},[],{"trials":256,"activeCount":58},[],{"trials":258,"activeCount":58},[],{"intervention":260,"totalTrials":54,"cells":261},"Cholecalciferol",{"EARLY_PHASE1":262,"PHASE1":264,"PHASE2":266,"PHASE3":268,"PHASE4":270,"NA":272},{"trials":263,"activeCount":58},[],{"trials":265,"activeCount":58},[],{"trials":267,"activeCount":58},[],{"trials":269,"activeCount":58},[],{"trials":271,"activeCount":58},[],{"trials":273,"activeCount":58},[274],{"nctId":275,"briefTitle":276,"status":125,"phases":277,"primaryCompletion":278,"completion":278,"start":279,"enrollment":280,"conditions":281,"interventions":283},"NCT01412710","Vitamin D Supplementation on Cardiovascular Risk Factors",[51],"2013-09","2011-07",92,[282],"Type 2 Diabetes",[260],{"intervention":285,"totalTrials":54,"cells":286},"Methylphenidate 0.15 mg\u002Fkg",{"EARLY_PHASE1":287,"PHASE1":289,"PHASE2":291,"PHASE3":293,"PHASE4":295,"NA":297},{"trials":288,"activeCount":58},[],{"trials":290,"activeCount":58},[],{"trials":292,"activeCount":58},[],{"trials":294,"activeCount":58},[],{"trials":296,"activeCount":58},[],{"trials":298,"activeCount":58},[299],{"nctId":300,"briefTitle":301,"status":125,"phases":302,"primaryCompletion":303,"completion":304,"start":305,"enrollment":306,"conditions":307,"interventions":308},"NCT00050622","Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)",[51],"2004-08","2005-06","2001-09",154,[206],[285,309,310],"Methylphenidate 0.3 mg\u002Fkg","Methylphenidate 0.6 mg\u002Fkg",{"intervention":309,"totalTrials":54,"cells":312},{"EARLY_PHASE1":313,"PHASE1":315,"PHASE2":317,"PHASE3":319,"PHASE4":321,"NA":323},{"trials":314,"activeCount":58},[],{"trials":316,"activeCount":58},[],{"trials":318,"activeCount":58},[],{"trials":320,"activeCount":58},[],{"trials":322,"activeCount":58},[],{"trials":324,"activeCount":58},[325],{"nctId":300,"briefTitle":301,"status":125,"phases":326,"primaryCompletion":303,"completion":304,"start":305,"enrollment":306,"conditions":327,"interventions":328},[51],[206],[285,309,310],{"intervention":310,"totalTrials":54,"cells":330},{"EARLY_PHASE1":331,"PHASE1":333,"PHASE2":335,"PHASE3":337,"PHASE4":339,"NA":341},{"trials":332,"activeCount":58},[],{"trials":334,"activeCount":58},[],{"trials":336,"activeCount":58},[],{"trials":338,"activeCount":58},[],{"trials":340,"activeCount":58},[],{"trials":342,"activeCount":58},[343],{"nctId":300,"briefTitle":301,"status":125,"phases":344,"primaryCompletion":303,"completion":304,"start":305,"enrollment":306,"conditions":345,"interventions":346},[51],[206],[285,309,310],{"intervention":348,"totalTrials":54,"cells":349},"Stimulant medication therapy",{"EARLY_PHASE1":350,"PHASE1":352,"PHASE2":354,"PHASE3":356,"PHASE4":358,"NA":360},{"trials":351,"activeCount":58},[],{"trials":353,"activeCount":58},[],{"trials":355,"activeCount":58},[],{"trials":357,"activeCount":58},[],{"trials":359,"activeCount":58},[],{"trials":361,"activeCount":58},[362],{"nctId":363,"briefTitle":364,"status":125,"phases":365,"primaryCompletion":366,"completion":367,"start":368,"enrollment":369,"conditions":370,"interventions":371},"NCT00632619","Group-Based Behavioral Therapy Combined With Stimulant Medication for Treating Children With Attention Deficit Hyperactivity Disorder and Impaired Mood",[51],"2011-06","2011-09","2009-03",68,[206],[348]]